ARCHIVES

Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Takes Summer Publication Break.

August 2, 2002

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB.

October 8, 2004

Experts Raise Questions About Influential Swedish Trial Of Mammography Screening.

May 11, 2007

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990